PolyPid Announces Pricing of $6.2 Million Underwritten Public Offering of Ordinary Shares and Concurrent $4.4 Million Private Placement of Pre-Funded Warrants
PETACH TIKVA, Israel, March 29, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, announced today the pricing of an underwritten public offering of 14,660,000 ordinary shares, no par...
PolyPid Announces Proposed Underwritten Public Offering of Ordinary Shares
PETACH TIKVA, Israel, March 28, 2023 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, announced today that it has commenced an underwritten public offering of its ordinary shares, no par...
INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering
SARASOTA, Fla., March 27, 2023 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture...
Mogo Reports Results for Q4 & FY 2022
FY 2022 Revenue up 20% year over year to $68.9 million Q4 Adjusted EBITDA of $0.2 million, reaching positive Adjusted EBITDA one year ahead of previous guidance Targeting FY 2023 Adjusted EBITDA of $6 to $8 million Ended year with $30.8 million of cash and $37.5...
Kiora Pharmaceuticals Reports 2022 Financial Results; Provides Update on Clinical Development Progress
Encinitas, California--(March 23, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today is providing a business update and reporting financial results for the year ended December 31, 2022.CEO Commentary: "In 2022, we advanced our...
Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation Candidates
ROCKVILLE, Md., March 22, 2023 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced it has...
LiqTech International Announces Financial Results for Fourth Quarter and Full Year 2022
BALLERUP, Denmark, March 22, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the fourth quarter and fiscal...
Mogo Schedules Q4 2022 Earnings Conference Call
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital payments and financial technology company, today announced it will hold a conference call and webcast to discuss its Q4 2022 financial results on Thursday, March 23,...
SenesTech Announces 2022 Financial Results
Product Sales Break $1 Million Sales Increase 77% for the Year PHOENIX, March 16, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for...
ARIANNE PHOSPHATE SELLS ITS JAMES BAY AREA ROYALTY FOR $2,350,000
-transaction significantly increases financial position without any shareholder dilution SAGUENAY, QC, March 16, 2023 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company,...
LiqTech International to Discuss Fourth Quarter and Fiscal Year 2022 Results on Wednesday, March 22, 2023
Management to Host Conference Call on Wednesday, March 22, 2023, at 9:00 a.m. ET BALLERUP, Denmark, March 15, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and...
Shuttle Pharmaceuticals Provides Fiscal Year 2022 Corporate Update
ROCKVILLE, Md., March 15, 2023 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a...
LiqTech Receives New Zealand Pool System Order
BALLERUP, Denmark, March 15, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced the receipt of a $0.5 million order for four commercial...
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2022
Full Year 2022 vs. Full Year 2021: Record Net Revenues: $109.9 million, a 7% increase ITS Revenue: $68.9 million - DME Revenue: $41.0 million, increases of 5% and 12% Adjusted EBITDA: $20.7 million 2023 Full Year Guidance - Revenue Growth 8% to 10%; Adjusted EBITDA...
InfuSystem to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
Kiora Pharmaceuticals Announces the Acceptance of Three Abstracts at the 2023 ARVO Annual Meeting
Encinitas, California--(March 10, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced three abstract acceptances for oral and poster presentation at the 2023 Association for Research in Vision and Ophthalmology (ARVO) meeting...
Cadrenal Therapeutics Recognizes National Kidney Month with Goal to Advance Tecarfarin for Severely Underserved Patient Population
Tecarfarin, a novel therapy designed for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with End Stage Renal Disease and Atrial Fibrillation, may be a new treatment option for this underserved patient population PONTE VEDRA,...
Shuttle Pharmaceuticals Engages UI Pharmaceuticals for Formulation and Clinical Batch Manufacture of Ropidoxuridine for Brain Tumor Clinical Trial
ROCKVILLE, Md., March 9, 2023 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced it has...
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2022 Results
Record revenue in Q4 2022 with $21.0 million in total net sales, up 18% from the prior year quarter, a net loss of $1.4 million and an Adjusted EBITDA profit of $0.4 million. Full year total net sales of $72.0 million with $60.1 million from Tru Niagen LOS ANGELES -...
LiqTech Product Manager of Membranes Esra Eray Awarded DAKS PhD Prize by the Danish Ceramic Society
BALLERUP, Denmark, March 7, 2023 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, today announced that Esra Eray, Product Manager of Membranes for LiqTech, has...
Reviva Pharmaceuticals to Present at the 35th Annual Roth Conference
CUPERTINO, Calif., March 07, 2023 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
S&W Seed Company to Participate in 35th Annual Roth Conference
LONGMONT, Colo., March 7, 2023 -- S&W Seed Company (Nasdaq: SANW) today announced Company's President and Chief Executive Officer, Mark Wong, will participate in a Panel hosted by ROTH Capital titled "AG Biologicals and Gene Editing", on Monday, March 13, 2023 at...
PolyPid to Present at the Barclays Global Healthcare Conference
PETACH TIKVA, Israel, March 07, 2023 -- PolyPid Ltd. (Nasdaq: PYPD), ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will present at the Barclays Global Healthcare Conference, which is being...
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
WINTER SPRINGS, Fla., March 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is...
ARIANNE RECEIVES FULL REPORT CONFIRMING THE ABILITY TO USE ITS CONCENTRATE IN ADVANCED BATTERY APPLICATIONS
-physical samples of the purified phosphoric acid have also been received DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, March 6, 2023 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a...